Moderna will report its fourth-quarter 2025 earnings this morning in an investor call that’s taken on even more interest in ...
Drug observers puzzled by vaccine maker, which made a killing on COVID-19, failing to read the room with new administration. Moderna puts heat on FDA vaccines chief who's already been rebuked once by ...
The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results